Positron AI Raises $230 Million Series B at Over $1 Billion Valuation to Scale Energy-Efficient AI Inference
4.2.2026 14:00:00 CET | Business Wire | Press Release
Positron AI, the leader in energy-efficient AI inference hardware, today announced an oversubscribed $230 million Series B financing at a post-money valuation exceeding $1 billion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204250472/en/
Thomas Sohmers (L), CTO and cofounder, and Mitesh Agrawal (R), CEO of Positron AI (Credit: Kavita Agrawal)
The round was co-led by ARENA Private Wealth, Jump Trading, and Unless, and includes new and strategic investment from Qatar Investment Authority (QIA), Arm, and Helena. Existing investors Valor Equity Partners, Atreides Management, DFJ Growth, Resilience Reserve, Flume Ventures, and 1517 also participated. The financing validates Positron's mission to make AI inference dramatically cheaper and more energy-efficient at scale.
“We're grateful for this investor enthusiasm, which itself is a reflection of what the market is demanding,” said Mitesh Agrawal, CEO of Positron AI. “Energy availability has emerged as a key bottleneck for AI deployment. And our next-generation chip will deliver 5x more tokens per watt in our core workloads versus Nvidia’s upcoming Rubin GPU. Memory is the other giant bottleneck in inference, and our next generation Asimov custom silicon will ship with over 2304 GB of RAM per device next year, versus just 384 GB for Rubin. This will be a critical differentiator in workloads including video, trading, multi-trillion parameter models, and anything requiring an enormous context window. We also expect to beat Rubin in performance per dollar for specific memory-intensive workloads.”
Positron is building the infrastructure layer that makes AI usable at scale by lowering the cost and power required to run modern models. The company's shipping product, Atlas, is an inference system designed for rapid deployment and scaling. Atlas is also a fully American-fabricated and manufactured silicon and system, enabling fast production ramp and dependable supply for customers who need capacity quickly.
“Memory bandwidth and capacity are two of the key limiters for scaling AI inference workloads for next-generation models,” said Dylan Patel, founder and CEO of SemiAnalysis, an advisor and investor in Positron. SemiAnalysis is a leading research firm specializing in semiconductors and AI infrastructure that provides detailed insights into the full compute stack. “Positron is taking a unique approach to the memory scaling problem, and with its next-generation Asimov chip, can deliver more than an order of magnitude greater high-speed memory capacity per chip than incumbent or upstart silicon providers.”
Jump Trading Leads After Deploying Atlas
A key highlight of the round is Jump Trading's decision to co-lead after first becoming a customer.
"For the workloads we care about, the bottlenecks are increasingly memory and power—not theoretical compute,” said Alex Davies, Chief Technology Officer of Jump Trading. “In our testing, Positron Atlas delivered roughly 3x lower end-to-end latency than a comparable H100-based system on the inference workloads we evaluated, in an air-cooled, production-ready footprint with a supply chain we can plan around. The deeper we went, the more we agreed with Positron’s roadmap—Asimov and the Titan systems—as a memory-first platform built for future workloads. We invested because Positron combines traction today with a roadmap that can reshape the cost curve and capabilities for inference.”
“Jump Trading came to Positron as a customer,” said Agrawal. “As they saw our roadmap for Asimov, our custom silicon, and Titan, our next-generation system, they chose to step up as a co-lead investor. A customer becoming an investor is one of the strongest validations we can receive. It signals both technical conviction and real-world demand.”
Building Toward Asimov and Titan: A Memory-First Platform for Next-Generation Inference
Positron's next-generation custom silicon, Asimov, is designed around the reality that modern AI workloads are increasingly limited by memory bandwidth and capacity, not just compute flops. Asimov is designed to support 2 terabytes of memory per accelerator and 8 terabytes of memory per Titan system at similar realized memory bandwidth to NVIDIA's next-generation Rubin GPU. At rack scale, this translates to memory capacity of well over 100 terabytes.
“As AI inference scales, efficiency and system design matter more than raw benchmarks,” said Eddie Ramirez, Vice President of Go-to-Market, Cloud AI Business Unit, Arm. “Positron’s memory-centric approach, built on Arm technology, reflects how tightly coupled systems and a broad ecosystem come together to deliver scalable, performance-per-watt gains in next-generation AI infrastructure.”
This memory-first architecture unlocks high-value inference workloads, including long-context large language models, agentic workflows, and next-generation media and video models. Positron is on track to tape out its Asimov chip just 16 months after its June Series A financing gave it the resources to fully launch the design process, and the company intends to maintain this pace with future chips. “To us, development speed is an essential competitive advantage,” said Agrawal. “Competing with Nvidia means matching their shipping frequency, and we have designed our organization around that goal.”
“Positron is solving one of the most important bottlenecks in AI: delivering inference at scale within real-world power and cost constraints,” said Ari Schottenstein, Head of Alternatives at ARENA Private Wealth. “The combination of shipping traction today with Atlas, plus a credible path to Asimov, creates a rare opportunity to define a new category in AI infrastructure.”
Positron is building this platform with an ecosystem of industry leaders, including Arm, Supermicro and other key technology and supply-chain partners.
Momentum and Growth Trajectory
Positron expects strong revenue growth in 2026, positioning the company to become one of the fastest-growing silicon companies ever, achieving large-scale commercial traction in roughly 2.5 years from company launch. The company is working with multiple frontier customers across cloud, advanced computing, and performance-sensitive verticals, and continues to expand deployments and customer programs.
About Positron AI
Positron AI builds purpose-built hardware and software to make AI inference dramatically cheaper and more energy-efficient. Positron's shipping product, Atlas, is designed for rapid, scalable deployment, and the company's next-generation custom silicon, Asimov, targets tape-out toward the end of 2026 with production in early 2027. Positron's systems are built to serve long-context and next-generation AI workloads with leading economics. Learn more at positron.ai.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260204250472/en/
Contacts
Media Contact:
Helen Cho
Bonfire Partners
press@bonfirepartners.io
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press Release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR) patient populations, treatment settings, and manifestations of disease. Additionally, the data expand the potential application of RNAi to uncontrolled hypertension, the world’s leading cause of cardiovascular disease. “With the power of our RNAi therapeutics platform, we have the potential to make a transformational impact on cardiovascular care,” said Pushkal Garg, M.D., Chief Research and Development Officer at Alnylam. “The data presented at ESC demonstrate the consistency of clinical outcomes achieved by RNAi-powered TTR silencing, reinforcing our conviction in AMVUTTRA as a first-line treatment option for ATTR-CM. With
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press Release
Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon company, in strategic partnership with the Emirates Falconers’ Club, at ADNEC Centre Abu Dhabi. The exhibition runs until 6 September. The falcon, owned
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press Release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press Release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press Release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom